Term
|
Definition
Flucytosine
Prodrug: 5 fluorocytosine-->5-flurouracil (5-FU)
MoA: 1)Transported into cell by fungal specific enzyme CYTOSINE PERMEASE 2)Metabolism: 5 fluorocytosine-->5 fluorouracil by CYTOSINE DEAMINASE
a. 5FU-->5FUMP-->5FdUMP-->inhibits Thymidylate synthetase (impairs DNA synthesis)
b. 5FUMP-->5FUTP-->altered RNA synthesis (incorp. into mRNA-->miscoding during translation)
TX: serious systemic fungal infections; used with Amphotericin B; Candidal Endocarditis (lipid prep AmB), Candidal Endophthalmitis, Cryptococcemia, meningitis (AmBD)
ADR: GI, Hepatic, Bone marrow suppression
BBW: caution in renal impairment; monitor hematological, renal, & hepatic func.
*PO, w/o Food, excreted in urine, Pregnancy C |
|
|
Term
|
Definition
Amphotericin B-->Polyene
FungiCIDAL
AmBD (regular prep); L-AmB, ABLC, ABCD (lipid formulations-->higher distribution in liver, spleen & lung, therefore lower incidence of renal toxicity & dysfunction)
MoA: Binds to ERGOSTEROL and forms pores which increase membrane permeability
TX: Histoplasmosis, Blastomycosis, Coccidioidomycosis (primary fungal infections); Mucormycosis, Cryptococcal, Cutaneous and mucosal candida, Aspergillosis (Opportunistic) ADR: 1) Infusion reactions: GI, Thrombophlebitis, Fever, chills, hypotension 2) Delayed:Renal dysfunction/nephrotoxicity, vascular, azotemia (increase of nitrogenous products in blood) 3)Blood Dyscrasias: due to decreased Epoeietin; normochromic & macrocytic anemia 4) GI 5) Skin rash *6)Granulocyte infusions may produce pulmonary toxicity (mostly with LIPID formulations) BBW: DO NOT use in NON-invasive forms of fungal disease in pt. w/ normal neutrophil counts
*Highly protein bound, highest concentration in the kidney, Pregnancy B, IV |
|
|
Term
|
Definition
Nystatin-->Polyene
MoA: See Amphotericin B
TX: Local GI infections ONLY |
|
|
Term
|
Definition
Azoles
MoA: alter fungal membrane permeability/function; Competitive inhibitor of CYP450 3A dependent lanosterol 14-α demethylase (blocks lanosterol-->ergosterol)-->inhibits ergosterol synthesis
Binds to P450-->N3 binds to ferric iron in fungal P450 heme; N1 affinity for apoprotein important too
1. Imidazoles: can also inhibit HUMAN CYP450
2. Triazoles: selective for fungal |
|
|
Term
|
Definition
Ketoconazole-->Imidazole
FungiSTATIC
MoA: Competitive inhibitor of CYP450 3A dependent lanosterol-14-α-demethylase (blocks lanosterol>ergosterol); altered cell membrane permeability and function
TX: Dermatophytes (Primary-->T. vesicolor Alternative-->T. corporis, T. cruris, T. pedis), Paracoccidioidmycoses (alternative)
ADR: GI (dose-dependent), Hepatic (BBW), Dermatological, Endocrinological abnormalities (cortesol & sex hormones are mediated by CYP450 which is blocked by ketoconazole so sex abnormalities & adrenal insufficiency may occur), HTN
DIs: Inducers of CYP450 (PPIs, antacids, rifampin) can lower keto's level; Keto can increase Warfarin levels
BBW: rare but FATAL hepatitis, usually w/in 3 mo. increase risk female & age *PO, w/ FOOD (high fat/acidic, low carb), bile, Pregnancy C
|
|
|
Term
|
Definition
Itraconazole-->Triazole
FungiSTATIC
MoA: see Ketoconazole
Admin:Capsule (normal, NOT mucositis), Oral Solution--HPBCD (mucositis, bone marrow transplant, HIV, infants/children, chemo) IV (if CrCl<30ml/min discontinue & give orally)
TX: Blastomycoses** (CNS), Dermatophytes (Onychomycosis--Primary), Histoplasmosis**, Paracoccidioidmycoses, Sporotrichiosis; Alternative: Cryptococcosis** (non-meningitis/AIDS), dematiaceous molds. **DO NOT use if life-threatening
ADR: well tolerated GI, Skin, CNS, Metabolic (hypertriglycerdemia, hypokalemia), Other (pedal edema, decreased testosterone-->rare) *600mg.day: HTN, adrenal insufficiency, lower limb edema
BBW: Do NOT use in patients w/ evidence of ventricular dysfunction or history of CHF (chronic/untreated)--itraconazole can produce negative inotropic effect
DIs: see Ketoconazole
*PO/IV, w/FOOD-->Capsule, w/o FOOD-->Solution, Pregnancy C |
|
|
Term
|
Definition
Fluconazole-->Triazole
FungiSTATIC
MoA: See Ketoconazole
TX:Candidiasis (EXCELLENT), Cryptococcuc (non-meningitis/AIDS), Onychomycosis; Alternative: other Dermatophytes
ADR:well tolerated--GI, Dermatological (exfoliative derm.), *Chronic (>6 months) TX-->alopecia, anorexia, headache
DIs: LOTS!...increases Phenytoin, Cyclosporine & Warfarin levels; Fluconazole decreased by Rifamycins, Cimetidine; increased by Hydrochlorothiazides
*Crosses BBB, urine, CYP 2C9, 3A4, 2C19, Pregnancy D |
|
|
Term
|
Definition
Voriconazole-->Triazole
FungiSTATIC
MoA: See Ketoconazole
TX: Aspergillus (invasive), Blastomycosis (CNS), Dematiaceous molds, Candida spp, Scedosporium, Fusarium spp; Alternative-->Coccidioidmycosis
ADR: Hepatic toxicity (usually immunocompromised), GI, CNS, Ophthalmic, prolonged QT, High doses-->hypoglycemia, pneumonitis, confusion/hallucinations, in immunosuppressed-->greater risk squamous cell carcinoma
DIs: drugs that inhibit/induce 3A4, 2C9, 2C19; drugs prolong QT interval, high fat meals DECREASES AUC & Cmax
*CrCl,50ml/min-->take off IV, switch to PO
*Tablets contain Lactose so do not give if lactose intolerant
*Crosses BBB, urine, WITHOUT food, Pregnancy D |
|
|
Term
|
Definition
Posaconazole-->Triazole
FungiCIDAL & STATIC
MoA: See Ketoconazole, EXCEPT binds to CYP51-->more potent inhibitor
**Extended side chain enables tighter binding to CYP51, thus less susceptible to mutation in enzyme
TX: Prevention Candida (STATIC) & Aspergillus (CIDAL) in severely immunocompromised, Oropharyngeal Candidiasis; Alternative: Chromoblastomycosis, Fusariosis, Mucormycosis
ADRs: usually mild-->GI, Liver, CNS (H/A, dizziness), Skin, decreases in serum K+ levels
DIs: inhibits CYP 3A4
*Take during or immeadiately after meal, acidic & fat, feces, PO, Pregnancy C, split doses increases absorption, NO renal adjustment |
|
|
Term
|
Definition
Miconazole-->Imidazole
FungiSTATIC
MoA: exact unknown; similar to Ketoconazole; alters permeability of cell membrane, may also alter RNA & DNA metabolism or produce intracellular accumulation of peroxides
TX: systemic Psedudoallescheriosis (IV) & skin/vaginal Candida & dermatophytes
ADRs: Injection site phlebitis, rash, purritus, GI, fever, chills, decreased serum sodium, hyperlipemia, Cardiac (arrhythmia, tachycardia), Hematologic (decreased hematocrit, thrombocytopenia)
DIs: Amphotericin B-->antagonize, Oral anticoagulants-->enhance, similar interactions as Ketoconazole
*IV/Top, urine, CYP450, Pregnancy C |
|
|
Term
|
Definition
Terbinafine-->Allylamine
FungiCIDAL-->several times more potetnt than naftifine
MoA: inhibits squaline epoxidase (key enzyme in sterol biosynthesis)-->alters cell membrane=DEATH
TX: Dermatophytes: Onychomycosis--Primary, T. pedis/capitis/corporis/cruris--Alternative, Chromoblastomycosis (Tertiary), Sprortrichosis (Alternative)
ADR: Changes in ocular lens and retina, neutropenia, GI, Liver enzyme abnormalities, Skin, Taste disturbances (2x more likely in women)
BBW: DO NOT use in patients w/ acute or chronic liver disease
DIs: Cimetidine increases Terbenafine, Rifampin decreases terbinafine
*PO, w/ or w/o FOOD, High protein binding, accumulates in sebum, skin, hair, & nail, CYP 2C8, 2C9, 2C19, 1A2, 3A4, urine, Pregnancy B |
|
|
Term
|
Definition
Naftifine-->Allylamine
MoA: See Terbinafine
TX: skin infections |
|
|
Term
|
Definition
Caspofungin-->Echinocandin
FungiCIDAL Forms salts w/ 2 acetates w/ 2 free NH2
MoA: NON-COMPETITIVE inhibition of beta-1,3-D-glucan synthase-->no beta-1,3-D-glucan-->disruption of creation of fungal cell wall
TX:Invasive aspergillus infections resistant to other treatment; empirical tx of fever and neutropenia; Candidemia; Invasive Candidiasis; Esophageal Candidiasis
ADRs: Pyrexia, diarrhea, increased LFT, hypokalemia, infusion reactions, hepatic dysfunction
DIs: CYP inducers may lower plasma levels of Caspofungin, tacrolimus, Ciclosporin, Rifampin
*IV, urine & feces, NO renal adjustment, Pregnancy C, semisynthetic lipopeptide |
|
|
Term
|
Definition
Micafungin-->Echinocandin
FungiCIDAL
Forms salts w/ 2 acetates w/ 2 free NH2
MoA: NON-COMPETITIVE inhibition of beta-1,3-D-glucan synthase-->no beta-1,3-D-glucan-->disruption of creation of fungal cell wall
TX: Candidemia, invasive candidiasis, esophageal candidiasis, prophylaxis of candidal infections in patients undergoing stem cell transplant
ADRs: Infusion reactions, Metabolism & nutrition disorders, diarrhea, hypokalemia, hepatic dysfunction
DIs: Ciclosporine & Nefidipine
*IV, feces, Pregnancy C |
|
|
Term
|
Definition
Anidulafungin-->Echinocandin
FungiCIDAL
Forms salts w/ 2 acetates w/ 2 free NH2
MoA: NON-COMPETITIVE inhibition of beta-1,3-D-glucan synthase-->no beta-1,3-D-glucan-->disruption of creation of fungal cell wall
TX: Candidemia, invasive candidiasis, esophageal candidiasis, prophylaxis of candidal infections in patients undergoing stem cell transplant
ADRs: Pyrexia, diarrhea, increased LFTs, hypokalemia, H/A, neutropenia
DIs: Ciclosporine
*IV, feces, Pregnancy C
|
|
|
Term
|
Definition
Griseofulvin-->Antifungal antibiotic
Fungi
MoA: inibits mitosis through disruption of mitotic spindle
TX: Alternative: T. corporis/pedis/cruris/capitis
ADRs: Allergic rxn, GI, H/A, dizziness, blood dyscrasias (bone marrow suppression), heptotoxicity, parasthesis of hands and feet, photosensitivity, lupus-like syndrome
DIs: Barbituates decrease levels
*PO, CYP 3A4, urine, Pregnancy C |
|
|
Term
|
Definition
Ciclopirox
Fungi
MoA: unknown; may act as chelator of Fe and Al which are required for fungla enzymes that detoxify peroxide and other reactive oxygen species
TX:
Loprox cream & lotion-->T. pedic/cruris/corporis
Loprox gel & shampoo-->T. pedis/cruris & seborrheic dermatitis
Penlac-->topical for mild-mod onychomycosis **Removal of unatteched infected nail monthly is required...flammable
ADRs:
Loprox: pruritis, burning, worsening of S/Sx
Penlac: nail disorders, burning, erythema of proximal nail bed
DIs: reduce effectiveness of systemic agents? |
|
|
Term
|
Definition
Quinoline
Historically excellent choice
TX: Malaria
MoA: unknown |
|
|
Term
|
Definition
Quinolines & Analogues
1. Mefloquine
4-Quinoline methanols-->can cause depression & suicidal thoughts
Another e.g. Cinochona alkaloids
2. Primaquine
8-Aminoquinolines |
|
|
Term
|
Definition
Quinolines & Analogs
1. Quinacrine
9-Aminoacridines
2. Hydroxychloroquine
7-Chloro-4-aminoquinolines-->have become standard anti-malarials
Another E.g.-->Chloroquine |
|
|
Term
|
Definition
Quinolines and Analogs
Later generation chlroquines-->for chloroquine resistant strains of P. falciparaum
1. Amidiaquine
2. Tebuquine-->t-butyl group reduces cross-resistance
Both active but CHRONIC ACTIVITY
*If phenyl-Cl in Tebuqine replaced with propyl or isoproyl, may promising and decrease toxicity
|
|
|
Term
|
Definition
Artemisinin & Analogs
Developed in China from Artemisia annua plant; active ingred. in ginghaosu (tea)
1, 2, 4-trioxosequiterpene...**Endoperoxide is essential
Limited bioavailability & hydrolytically unstable
MoA: irreversibly decomposes, generating free radicals that alkylate & oxidizes proteins and lipids...activated by intra-parasitic heme
TX: Malaria & Hemorrhoids
Other E.g.: Artemether, Artesunate, Arteether |
|
|
Term
|
Definition
Coartem (artemether/lumefantrine)
1:6 fixed dose combination
MoA: inhibit nucleic acid and protein synthesis
TX: Malaria |
|
|
Term
|
Definition
Halofantrine
MoA: unknown, but does prolong QT interval
TX: malaria
*Major metabolite (n-Butyl halfatrine) is equally active
**Erratic GI absorption
***Contraindicated in use of drugs known to prolong QT interval |
|
|
Term
|
Definition
Malarone (Atovaquone/Proguanil HCl)
250mg:100mg
MoA:
Atovaquone-->selective inhibitor of parasite mitochondrial electron transport
-->FQ derivative
Proguanil-->primarily by metabolite cycloguanil (via CYP2C19) a DHF reductase inhibitor
TX: Malaria
**Synergistic effect |
|
|
Term
|
Definition
Halogenated Uridines-->Idoxuridine
1st class anti-DNA virals
NucleoSIDE
Ribose
Analog of thymidine; triphosphate is incorporated in the place of thymidine-->false base pairing
MoA: destabilize/alter H bonds between nucleic acids-->alter DNA structure
TX:
Idoxuridine-->ophthalmic for HSV keratoconjuctivitis
Trifluorothymidine-->HSV1 & 2 |
|
|
Term
NucleoSIDE
NucleoTIDE
DNA linkage
3'
5'
Base |
|
Definition
NucleoSIDE-->unphosphorylated
NucleoTIDE-->phosphorylated
DNA Linkage-->3'-5' phosphodiester linkage
3'-->elongation
5'-->phosphorylation
Base-->pairing |
|
|
Term
1. [image] 2.[image]
3.[image] 4. [image] |
|
Definition
1. Adenine
2. Cytosine
3. Guanine
4. Thymine
A & G-->pyrimadines C & T-->purines |
|
|
Term
|
Definition
1. Acyclovir (9-[(2-hydroxyethoxy)methyl]guanine)
NucleoSIDE
Missing 2'OH-->recognized as DNA
Prodrug-->6-deoxy acyclovir (missing carbonyl)
**Must be converted to triphosphate by viral thymidine kinase
MoA: inhibits viral DNA synthesis-->incorporated into viral chain then elongation terminated (b/c missing 3'OH)
TX: HSV-1 & HSV-2, Varicella (VZV), Epstein-Barr (EBV)
ADR: N/V/HA, neurotoxicity, reversible renal dysfunction
DIs: Zidovudine, Valoproate, Merperidine
*IV, urine
2. Valacyclovir-->amino-acid ester prodrug-->enhanced GI absorption |
|
|
Term
|
Definition
Cidofovir
NucleoTIDE analog of CYTOSINE-->actual nucleotides are not used as drug b/c won't be able to get into cell...phosphoNATE group can get into cell
MoA:converted to diphosphate analog that acts as a competitive inhibitor of dCTP as an alternate substrate for DNA polymerase (selectively inhibits DNA polymerase)
TX: HSV-1 & 2 (acyclovir-resistant), VZV, EBV, CMV retinitis in AIDS pts
ADR: N/V/D, rash, asthenia, anterior uveitis
BBW: Nephrotoxicity (dose related), neutropenia, only for CMV retinits in AIDS
Pregnancy X
*Give with Probenecid to decrease elimination rate, IV, urine |
|
|
Term
|
Definition
1. Famciclovir
NucleoSIDE
Diacetyl ester prodrug of Penciclovir (#2)-->after admin, deacetylated (hydrolysis) & oxidized to form Penciclovir (only active metabolite) in order to be phosphorylated
MoA: inhibits viral DNA synthesis; NOT a chain terminator
TX: HSV-1 & 2, VZV
ADR: N/D/HA, neutropenia, encephalitis
*PO, urine |
|
|
Term
|
Definition
Ganciclovir
NucleoSIDE-->acyclic deoxyguanosine analog
Valgancyclovir-->prodrug
MoA: selective inhibitor of VDNA polymerase; chain terminator
TX: greater activity againts CMV & EBV than acyclovir in AIDS, CMV retinitis, HSV
ADR: N/V/CNS (HA, psychosis, confusion, convulsion, coma)
DIs: increased nephrotoxicity w/ AGs, AmpB, cyclosporine, tacromilis
BBW: Myelosuppression
*Urine, PO, IV, implant |
|
|
Term
|
Definition
1. Vidarabine
NucleoSIDE analog of adenosine-->Arabinose sugar
Deaminated rapidly by adenine deaminase (host enzyme)-->arabinosyl hypoxanthine (weak antiviral)
MoA:intereferes w/ cprrect purine position & effective H bond formation w/ adjacent OH; destabilize duplex chain-->falls apart
TX: HSV 1 & 2 encephalitis, oint for HSV keratoconjunctivitis
2. Ribavirin
NuceloSIDE analog of guanine AND adenine-->NH2 & C=O can rotate to mimic both
Ribose sugar
MoA: inhibits VRNA polymerase, mRNA, & nucleic acid synthesis
TX: BROAD SPECTRUM (b/c of switching), Influ A & B, HSV 1&2, measles, acute hepatitis, serious RSV infection, delay onset of full blown AIDS |
|
|
Term
|
Definition
Entecavir
NucleoSIDE analog of guanosine
MoA: selectively inhibits HBV (hep B) polymerase (RT)-->even though missing 2' OH (mimic DNA), will stop RNA synthesis b/c RT uses DNA to make RNA
TX: HBV |
|
|
Term
|
Definition
Oseltamivir
MoA: Neuraminidase Inhibitor (prevents cleavage)
*Ethyl ester prodrug requiring ester hydrolysis for conversion to active form (Oseltamivir carboxylase)
TX: influenza pt >1y/o |
|
|